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IL-4 receptor expression on CD8
 
 
 
 T cells is 
required for the development of protective 
memory responses against liver stages 
of malaria parasites
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Luzia H. Carvalho, and Fidel Zavala
 
Department of Molecular Microbiology and Immunology, Malaria Research Institute, Bloomberg School of Public Health, 
Johns Hopkins University, Baltimore, MD 21205
 
IL-4 receptor (IL-4R)-deficient CD8+ T cells specific for the circumsporozoite protein of 
Plasmodium yoelii develop a severely impaired memory response after priming with 
parasites. Memory CD8
 
+
 
 T cells lacking the IL-4R are unable to establish a stable population 
residing in nonlymphoid organs, although they develop normally in lymphoid organs. Because 
memory cells from nonlymphoid organs disappear shortly after immunization, the protective 
antiparasitic activity of this T cell response also is lost. These results demonstrate that 
IL-4/IL-4R interactions on CD8
 
+
 
 T cells play a critical role in modulating the development 
and tissue distribution of memory cells induced by parasite immunization. They also indicate 
that memory cells residing in nonlymphoid tissues are critical for protective immunity 
against malaria parasites.
 
Naive CD8
 
 
 
 T cells undergo an intense process
of differentiation and proliferation after recog-
nizing antigenic peptides derived from viruses,
bacteria, or parasites (1). During the primary
response, CD8
 
 
 
 T cells develop antimicrobial
effector mechanisms as early as 24–48 h after
immunization, and acquire the capacity to cir-
culate between lymphoid and nonlymphoid
organs  (2, 3). These activated cells establish
memory populations within 20–25 d that ensure
the persistence of efficient protective immunity
against reinfection and disease (4–6). Memory
CD8
 
 
 
 T cells consist of subpopulations, which
may differ, in the expression of certain surface
markers (4, 7), cytokine receptors (8), and ana-
tomic location. Based on these criteria, at least
two different memory subsets have been de-
fined: “central” memory cells, which are found
primarily in lymphoid organs, and “effector”
memory cells, which reside in nonlymphoid
organs (9, 10). Although there is consensus that
memory CD8
 
 
 
 T cells are heterogeneous pop-
ulations, the precise molecular identity of the
different subsets and their respective role in pro-
tective immunity has not been elucidated fully.
The mechanisms by which CD8
 
 
 
 T cells
are activated and differentiated are controlled
by members of the cytokine-receptor 
 
 
 
-chain
family, particularly IL-2, IL-7, and IL-15.
These cytokines seem to promote the prolifera-
tion and survival of activated CD8
 
 
 
 T cells, and
ensure the maintenance of long-lived memory
CD8
 
 
 
 T cell responses (11). IL-4, another
member of this 
 
 
 
-chain cytokine family, also
plays a major role in the induction of certain
protective CD8
 
 
 
 T cell responses. Early studies
indicated that IL-4 was necessary to activate
CD8
 
 
 
 T cells in vitro (12), and to establish in
vivo antitumor protective immunity mediated
by CD8
 
 
 
 T cells (13). Studies with the rodent
malaria parasite 
 
Plasmodium yoelii
 
, using TCR
transgenic CD8
 
 
 
 T cells specific for the malaria
parasite epitope SYVPSAEQI, showed that
CD8
 
 
 
 T cells transferred into IL-4–deficient
mice cannot develop an antigen-specific CD8
 
 
 
T cell response after immunization with parasites
(14). In addition, a recent study demonstrated
that the induction of CD8
 
 
 
 T cell–mediated
protective immunity against 
 
Leishmania
 
 parasites
also is strictly IL-4 dependent (15).
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These findings, which indicate a major effect of IL-4 on
CD8
 
 
 
 T cell responses, raised basic questions regarding the
nature of the mechanisms that are involved in the regulatory
activity of IL-4. It is unknown whether IL-4 is needed dur-
ing the initial processes of activation of naive CD8
 
 
 
 T cells,
or whether it plays a role in the development and mainte-
nance of memory populations. Moreover, it has not been
determined whether IL-4 directly influences CD8
 
 
 
 T cell
function through the IL-4 receptor (IL-4R) expressed in the
surface of these cells or whether this cytokine effect is indi-
rect—through dendritic or CD4
 
 
 
 T cells—both of which
are known to exert strong regulatory effects on CD8
 
 
 
 T cell
responses. Here we describe studies using the rodent malaria
system 
 
P. yoelii
 
, which indicate that IL-4/IL-4R interactions
on CD8
 
 
 
 T cells are crucial to the development of memory
CD8
 
 
 
 T cells residing in nonlymphoid tissues. We also es-
tablish that this IL-4R–dependent memory subset is critical
to protection against malaria parasite infection.
 
RESULTS
IL-4R–deficient CD8
 
 
 
 T cells develop an abnormal response
 
To study the effect of IL-4 on CD8
 
 
 
 T cells, we crossed
BALB/c IL-4R KO mice (16) and BALB/c transgenic mice
expressing a TCR specific for the SYVPSAEQI epitope lo-
cated in the circumsporozoite protein of 
 
P. yoelii
 
 (2). After
the generation of F1 mice and subsequent backcross, we ob-
tained mice harboring TCR transgenic CD8
 
 
 
 T cells lacking
the IL-4R. Normal and IL-4R KO TCR transgenic CD8
 
 
 
T cells were used in adoptive transfer experiments to com-
pare their activation profile and homing behavior after in
vivo activation. Mice receiving IL-4R KO or normal trans-
genic CD8
 
 
 
 T cells were immunized 24 h later, with radia-
tion-attenuated 
 
P. yoelii
 
 sporozoites; the respective responses
were evaluated at different time points. As determined by
ELISPOT, the antigen-specific CD8
 
 
 
 T cell responses in
spleen of mice receiving normal or IL-4R KO cells were
similar 4 d after immunization. However, at days 6 and 10
after immunization, it became evident that the magnitude of
the T cell response in mice receiving IL-4R KO cells was
reduced severely compared with the response observed in
mice receiving normal T cells (Fig. 1 A). FACS analysis of
spleen cells after staining with SYVPSAEQI tetramers and
anti-CD8 antibodies confirmed the results of the ELISPOT
assay (Fig. 1 B). After day 13, mice receiving normal or IL-
4R KO cells had comparable numbers of memory cells in
spleen (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20042463/DC1).
The estimation of the absolute number of epitope-spe-
cific CD8
 
 
 
 T cells present at different time points after im-
munization also indicated that between days 4 and 10 after
immunization, the total number of IL-4R KO CD8
 
 
 
 T cells
present in spleen had decreased significantly compared with
the response of normal CD8
 
 
 
 T cells (Fig. S1). To evaluate
the survival rate of these cells, we examined the expression
of various anti- and proapoptotic markers. In three indepen-
dent experiments, FACS analysis of tetramer
 
 
 
/CD8
 
 
 
 nor-
mal and IL-4R KO cells indicated consistently that the level
of expression of Bcl-X
 
L
 
 in IL-4R KO cells was reduced at
day 4 after immunization (Fig. 1 C; and Fig. S2, available at
http://www.jem.org/cgi/content/full/jem.20042463/DC1).
Differences of similar magnitude in the expression of Bcl-
X
 
L
 
 were reported among long-lived (IL-7R
 
hi
 
) and short-
lived (IL-7R
 
lo
 
) activated CD8
 
 
 
 T cells (8). We did not de-
tect differences in the expression levels of Bcl-2 or Bax.
Figure 1. IL-4R KO CD8  T cells develop a reduced response after 
immunization. Naive normal or IL-4R KO transgenic CD8  T cells (5   105) 
were transferred into normal BALB/c mice which were subsequently 
immunized with 5   104 irradiation-attenuated sporozoites. The CD8  
T cell response of each was measured in pooled spleen cells, at different 
days after immunization. Each group consisted of four mice. (A) ELISPOT 
was used to determine the number of antigen-specific IFN- –secreting 
cells after incubation with antigen (14). Negligible numbers of IFN-  spots 
were obtained when cells were incubated without antigen. The data are 
representative of four independent experiments that yielded the same 
results. Error bars represent SEM. (B) FACS analysis of this response in 
spleen was performed by staining with anti-CD8–APC antibodies and 
tetramer-PE (2). Plots were gated on lymphocytes. The values in the top 
right corner represent the mean percentages of tetramer  cells within the 
total CD8  T cell population. The data are representative of four indepen-
dent experiments that yielded the same results. (C) Intracellular Bcl-XL 
staining of tetramer /CD8  T cells at day 4 after immunization. The mean 
fluorescent intensity of Bcl-XL expression is indicated. Gray line graph 
identifies normal CD8  T cells; solid line represents IL-4R KO CD8  T cells; 
and dotted line represents Ig isotype control. These data are representative 
of three independent experiments, using three to five mice per group. The 
values indicate the mean fluorescent intensity of Bcl-XL expression, the 
decrease observed in the IL-4R KO cells as compared with the normal cells 
was statistically significant (P   0.002; see Fig. S2). 
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Annexin-V staining of spleen cells from immunized mice did
not yield consistent differences between normal and IL-4R
KO transgenic CD8
 
 
 
 T cells (unpublished data). However,
this is not unexpected; the presence of apoptotic cells is diffi-
cult to evaluate ex vivo because they are cleared rapidly by
phagocytes (17, 18).
Using multiparameter FACS analysis after surface stain-
ing with tetramer-PE and anti-CD8-APC, we analyzed the
expression of several canonical cell surface markers that are
known to undergo changes after in vivo activation of these
T cells. First, we determined that memory responses gener-
ated by normal TCR transgenic CD8
 
 
 
 T cells developed
memory populations displaying surface phenotypes that were
consistent with those previously described for memory sub-
sets residing in lymphoid and nonlymphoid organs, usually
referred to as central and effector memory subsets, respec-
tively. Memory cells obtained from the liver, compared with
those from lymph nodes, express lower levels of CD62L and
CCR7 and higher levels of CD62P and CCR5. As ex-
pected, these CD8
 
 
 
 T cell populations express comparable
levels of CD44 (Fig. 2 A). Contrary to other reports (7, 19),
we found no differences in the expression of CD27 and
Granzyme B (unpublished data). We also determined that
naive normal and IL-4R KO CD8
 
 
 
 T cells used in adoptive
transfer experiments displayed an identical CD44
 
lo
 
 CD62L
 
hi
 
phenotype, typical of naive cells (reference 2; Fig. S3, avail-
able at http://www.jem.org/cgi/content/full/jem.20042463/
DC1). When comparing the in vivo activated normal and
IL-4R KO cells in spleen at different time points after im-
munization, the surface markers CD11a, CD11b, CD11c,
CD25, CD27, CD31, CD45RB, CD49d, CD69, CD71,
CD122, CCR5, IL-7R, granzyme B, P-selectin (Fig. S4, avail-
able at http://www.jem.org/cgi/content/full/jem.20042463/
DC1), and CD44 (Fig. 2 B) were expressed at similar levels.
However, there were significant differences in the expres-
sion of CD62L (Fig. 2 B). 4 d after immunization, normal
and IL-4R KO CD8
 
 
 
 T cells showed a characteristic profile
of CD62L expression with clearly identifiable CD62L
 
hi
 
 and
CD62L
 
lo
 
 subpopulations. In the following days, IL-4R KO
cells increased expression of this marker; by day 10 they be-
come a homogeneous population comprising mostly CD62L
 
hi
 
cells (Fig. 2 B).
 
IL-4R is necessary to develop memory cells 
in nonlymphoid organs
 
In view of these results suggesting that IL-4R KO CD8
 
 
 
 T
cells undergo an abnormal development in spleen, we per-
formed experiments to compare the homing of activated T
cells to lymph nodes and nonlymphoid organs. In these ex-
periments, normal or IL-4R KO transgenic CD8
 
 
 
 T cells
were transferred to naive mice that were immunized with
attenuated parasites 24 h later. The presence of antigen-spe-
cific CD8
 
 
 
 T cells in lymph nodes, liver, lung, kidneys, and
spleen was evaluated by FACS at different time points. 4 d
after immunization there were similar numbers of tetramer
 
 
 
/
CD8
 
 
 
 T cells in the lymphoid and nonlymphoid organs of
mice receiving normal or IL-4R KO cells (Fig. 3). A striking
difference became apparent 10 and 25 d after immunization;
the number of tetramer
 
 
 
/CD8
 
 
 
 cells resident in liver, kid-
ney, and lung organs was reduced severely in mice receiving
IL-4R KO cells.
Although memory IL-4R KO cells disappear from non-
lymphoid organs shortly after immunization, almost identical
numbers of tetramer
 
 
 
/CD8
 
 
 
 T cells were found at all times
in the lymph nodes of mice receiving normal or IL-4R KO
cells. The kinetics of these responses in spleen followed an
intermediate pattern. 10 d after immunization the responses
Figure 2. Characterization of memory CD8  T cell subsets and 
activated IL-4R KO CD8  T cells. Memory CD8  T cells were obtained 
20 d after immunization from liver and lymph nodes of mice that received 
normal transgenic CD8  T cells and were immunized with parasites. 
(A) Phenotypic analysis of normal memory T cells obtained from liver or 
lymph nodes (LN) was performed by flow cytometry after staining the cells 
with tetramer-PE, CD8-APC, and FITC-labeled antibodies against CD62L, 
CD62P, CCR5, CCR7, and CD44. Line graphs are gated on tetramer /CD8  
T cells. (B) Expression of CD44 and CD62L in activated CD8  T cells were 
assessed using spleen lymphocytes obtained from mice that received normal 
or IL-4R KO CD8  T cells, and were immunized with attenuated parasites, 
as described in the legend of Fig. 1. At specified days after immunization, 
FACS analysis was performed using anti-CD8–APC antibodies, tetramer-PE, 
and FITC-labeled antibodies against CD44 or CD62L. The line graphs represent 
data obtained after gating on tetramer /CD8  T cells. Solid gray graphs 
identify normal CD8  T cells, and solid lines represent IL-4R KO CD8  
T cells. The increase in the mean fluorescent intensity of CD62L expression 
observed in the IL-4R KO as compared with the normal cells after day 6 
was statistically significant (P   0.05). These data are representative of 
four independent experiments, using three mice per group at each time point. 
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of normal and IL-4R KO T cells were different in magni-
tude, whereas after day 13 the magnitude of the responses
was comparable (Figs. S1 and S3).
The estimation of the absolute number of memory cells in
the liver and lymph nodes at days 6 and 10 after immunization
confirmed the results suggested by FACS analysis shown in
Fig. 3. The total number of memory IL-4R KO cells in
liver—compared with normal memory CD8
 
 
 
 T cells—was
reduced strongly at day 10 (Fig. 4 A), whereas no differences
could be detected in lymph nodes (Fig. 4 B and Fig. S5, avail-
able at http://www.jem.org/cgi/content/full/jem.20042463/
DC1). The homing of memory cells to lungs and kidneys at
different time points after immunization followed a pattern
similar to that observed in liver (Fig. S6, available at http://
www.jem.org/cgi/content/full/jem.20042463/DC1).
This striking effect of IL-4R deficiency in the develop-
ment of memory CD8
 
 
 
 T cells in the liver was confirmed
further by IL-4 neutralization experiments. Mice that re-
ceived normal transgenic CD8
 
 
 
 T cells and were immu-
nized with parasites were treated with a monoclonal anti-
body against IL-4 at different time points. The development
of memory populations was evaluated 16 d after immuniza-
tion with parasites. The results indicated that treatment with
anti-IL-4 during the first 6 d after immunization induced a
severe reduction of the memory CD8
 
 
 
 T cell population in
the liver. In contrast, the memory populations residing in
lymph nodes were not affected. Treatment with anti–IL-4
between days 7 and 14 after immunization does not have a
major effect on the magnitude of any memory population
(Fig. 5). These results clearly indicate that IL-4 is critical
during the early events of the CD8
 
 
 
 T cell activation at a
time when activated cells migrate to nonlymphoid organs
and establish memory populations in these tissues.
 
Normal and IL-4R KO memory cells residing in lymphoid 
organs display identical phenotypic and functional properties
 
Although the previous experiments indicated that the num-
bers of normal and IL-4R KO memory cells residing in
lymph nodes were similar, we evaluated additional pheno-
typic and functional features of these memory cells. Pheno-
type analysis of memory CD8
 
 
 
 T cells residing in the lymph
nodes 25 d after immunization indicated that both IL-4R
KO and normal cells display an identical CD62L
 
hi
 
 CD44
 
hi
 
phenotype profile (Fig. 6 A). In addition, we found that
both cell types displayed a comparable capacity to produce
IL-2 and IFN-
 
 
 
 (Fig. 6 B). Finally, we performed experi-
Figure 3. IL-4R KO CD8  T cells do not develop peripheral memory. 
CD8  T cell responses developed by normal or IL-4R KO CD8  T cells were 
evaluated in different organs and at different time points after immunization 
with parasites. The adoptive transfer of transgenic CD8  T cells and 
immunization with parasites was performed as described in the legend of 
Fig. 1. Mononuclear cells that were purified from lymphoid and nonlym-
phoid organs were analyzed by FACS after staining with tetramer-PE and 
anti-CD8–APC. Plots represent tetramer /CD8  lymphocyte pools derived 
from four mice. The values in the top right corners represent mean per-
centages of tetramer  cells within the total CD8  T cell population. The 
decrease observed after 10 d in the percentages of IL-4R KO cells from 
liver, lung, and kidney compared with the normal cells was statistically 
significant (P   0.05). These data are representative of four independent 
experiments, using three mice per group at each time point. 
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ments to evaluate the in vivo proliferation of IL-4R KO and
normal memory cells after immunization. IL-4R KO and
normal memory cells isolated from lymph nodes 25 d after
immunization were labeled with CFSE, and equal numbers
of each cell type were transferred to naive mice. The recipi-
ent mice were immunized with sporozoites; the proliferative
response of these cells was assessed by evaluating CFSE dilu-
tion of tetramer
 
 
 
/CD8
 
 
 
 T cells using three-color FACS
analysis. The results indicated a nearly identical profile of
proliferation in both cell types (Fig. 6 C). Taken together,
the results of these experiments indicate that lymph node
cells lacking the IL-4R develop phenotypic, functional, and
proliferative characteristics that are identical to those of nor-
mal CD8  T cells.
IL-4R is critical for the development of protection against 
parasite challenge
The findings suggesting an unequal development of memory
subsets in the absence of the IL-4R raise the obvious ques-
tion about the in vivo protective activity of CD8  T cells
that are generated by normal and IL-4R KO cells. To evalu-
ate the antiparasitic activity of these CD8  T cell responses,
we performed experiments in which mice received equal
numbers of normal or IL-4R KO cells, and were immunized
with a low dose of attenuated P. yoelii sporozoites (5   103).
This parasite dose activates T cells but induces negligible
amounts of antibodies. At different time points, immunized
mice were challenged with viable sporozoites, and parasite
development in the liver was evaluated 36 h after infection
by using a real-time PCR assay (20). To ensure that the pro-
tective activity measured in this assay reflected only the effect
of transferred CD8  TCR transgenic cells, the endogenous
T cells were depleted by treatment with anti-CD8 antibody
before the transfer of transgenic cells, and with anti-CD4 4 d
after sporozoite immunization after activation and expansion
of CD8  T cells had occurred. The results of these protec-
tion experiments indicated that mice receiving normal or IL-
4R KO CD8  T cells were equally capable of inhibiting par-
asite development if challenged 6 d after immunization (Fig.
7 A). However, when these mice were challenged 16 d after
immunization, mice receiving IL-4R KO cells had lost their
protective immunity because they no longer inhibited the
development of the parasite liver stages (Fig. 7 B).
To gain new insights into the functional properties of
memory cell populations, we performed experiments to as-
sess the functional status of spleen memory cells after adop-
tive transfer into naive mice. It is known that transferred
memory cells purified from different organs acquire the ca-
pacity to home to nonlymphoid organs, regardless of their
tissue of origin or level of expression of CD62L (21–23).
Figure 4. Quantification of CD8  T cell responses in liver and 
lymph nodes. The total number of SYVPSAEQI–specific T cells present in 
the liver (A) and lymph nodes (B) of mice was determined 6 and 10 d after 
adoptive transfer of CD8  T cells and immunization with 5   104 attenu-
ated sporozoites. The estimation of the total number of epitope-specific 
cells was obtained by multiplying the percentage of tetramer /CD8  T cells 
(FACS) or IFN-  spots (ELISPOT) by the total numbers of lymphocytes 
isolated from the respective organs. Each histogram represents data from 
pooled cells obtained from four mice. These data are representative of four 
independent experiments, using three mice per group at each time point. 
Error bars represent SEM.
Figure 5. Treatment with anti-IL-4 antibody reduces the number 
of memory CD8  T cells in the liver. Naive transgenic CD8  T cells were 
transferred into normal mice, some of which received a daily i.p. injection 
of 0.1 mg of rat antibody against mouse IL-4 (11B11) at each of the indi-
cated days. Control groups received no treatment or a similar amount of 
nonspecific rat IgG. These mice were immunized with 5   104 attenuated 
sporozoites; 16 d later the number of epitope-specific CD8  T cells was 
evaluated by FACS in the liver and iliac lymph nodes of immunized mice. 
The data of each group were obtained from pooled lymphocytes that were 
taken from the lymph nodes or the liver. Each group consisted of four 
mice. Plots were gated on lymphocytes; the number in the upper right 
corner represents the frequency of tetramer /CD8  T cells in the CD8  
population. The data are representative of three independent experiments. 
The decrease observed in the percentages of the group that was treated 
with anti–IL-4 antibody during days  1 to 6, as compared with the 
untreated mice, was statistically significant (P   0.0196).IL-4 RECEPTOR–DEPENDENT MEMORY CD8+ T CELLS | Morrot et al. 556
Thus, we evaluated the homing properties and protective ca-
pacity of transferred normal and IL-4R KO CD8  T mem-
ory cells purified from spleen. These memory CD8  T cells
were obtained 25 d after immunization—a time point at
which they are no longer dependent on IL-4. IL-4R KO
memory cells consists mostly of CD62Lhi cells, whereas nor-
mal memory cells were CD62Lhi and CD62Llo. The number
of tetramer /CD8  memory cells used for these adoptive
transfer experiments (1.5   106) is the minimum necessary to
inhibit parasite development. As assessed by ELISPOT, the
results shown in Fig. 8 A indicate that normal and IL-4R
KO memory CD8  T cells were equally efficient at homing
to the spleen and liver. Most importantly, the new homing
profile of IL-4 R KO cells (Fig. 8 A) seemed to coincide
with the capacity of these cells to inhibit the development of
liver stage parasites as efficiently as normal memory cells (Fig.
8 B). The results of additional experiments aimed at evaluat-
ing the antiparasitic activity of CD62Lhi and CD62Llo normal
memory cells obtained from spleen were consistent with the
previous findings. In these experiments, normal memory
cells from spleen were stained with tetramer-PE, CD8-APC,
and anti-CD62L–FITC. Subpopulations expressing CD62Lhi
and CD62Llow were purified by FACS cell sorting, and equal
numbers of memory cells were transferred to naive mice
(Fig. 9 A). As shown in Fig. 9 B, these experiments indicated
that CD62Lhi and CD62Llo have a comparable capacity to
inhibit parasite development. Identical results were obtained
in experiments in which these memory CD8  T cell subsets
were purified based on staining with anti-Thy1.1 antibod-
ies—instead of tetramer—after transfer of Thy1.1 CD8  T
cells into Thy1.2 recipient mice (unpublished data).
Figure 6. Phenotypic, functional, and proliferative characteristics 
of memory CD8  T cells from lymph nodes. Memory CD8  T cells were 
obtained from lymph nodes of mice that received normal or IL-4R KO 
CD8  T cells and were immunized with parasites as described in the 
legend of Fig. 1. 25 d after immunization, these cells were analyzed by 
FACS. (A) Surface staining with anti-CD8-APC antibodies, tetramer-PE, 
and CD62L-FITC or CD44-FITC. Solid gray line graphs represent normal 
CD8  T cells and solid lines represent IL-4R KO cells. (B) ELIPSOT assay was 
performed to evaluate the capacity of these cells to produce IL-2 and 
IFN- , after antigen stimulation. Error bars represent SEM. (C) The in vivo 
proliferation of these memory cells also was assessed using normal and 
IL-4R KO memory CD8  T cells obtained from lymph nodes 25 d after 
immunization. These memory cells were labeled with CFSE, and transferred 
into mice which were immunized with 5   104 irradiation-attenuated 
sporozoites. The proliferation of the transferred tetramer /CD8  memory 
T cells was evaluated by FACS 3 d after immunization, after staining cells 
with tetramer and anti-CD8. Line graphs show the CFSE dilution patterns 
of cells, obtained by FACS after gating on tetramer /CD8  T cells. These 
data are representative of two independent experiments, using three mice 
per group at each time point.
Figure 7. Memory IL-4R KO CD8  T cells are not protective. An 
equal number of normal or IL-4R KO transgenic CD8  T cells were trans-
ferred to mice which were immunized 24 h later with 5   103 irradiated 
sporozoites. These mice were challenged with viable sporozoites at 6 d (A) 
or 16 d (B) after immunization. 34 h after parasite challenge, the livers of 
infected mice were excised to measure the parasite load using real-time 
PCR (20). The endogenous CD8  and CD4  T cells were eliminated by 
treatment with specific antibodies. The histograms represent the number 
of plasmodial rRNA copies. The data are representative of two independent 
experiments, using four mice per group at each time point.JEM VOL. 202, August 15, 2005 557
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Taken together, these results indicate that normal and
IL-4R KO CD8  T cells are capable of generating memory
cells with antiparasitic activity. However, their in vivo pro-
tective activity seems to be defined by their capacity to
home to, and remain in, nonlymphoid tissues.
DISCUSSION
The regulatory effects of IL-15, IL-7, and IL-2 on the devel-
opment of memory CD8  T cell responses has been well-
documented in studies using different viral systems. In con-
trast, the role of IL-4—which is critical to the development
of CD8  T cells responses against certain tumors and para-
sites—remains poorly characterized. In the present study we
used TCR transgenic CD8  T cells specific for the epitope
SIVPSAEQI of P. yoelii to compare normal and IL-4R KO
CD8  T cells with regard to the induction and maintenance
of memory responses. During the first 4 d after immuniza-
tion, IL-4R KO CD8  T cells developed an apparently nor-
mal proliferative activity and differentiation profile. How-
ever, as the response develops there is a drastic reduction of
memory IL-4R KO CD8  T cells in nonlymphoid organs,
and the establishment of memory populations in these tissues
is affected severely. This loss is particularly striking because
memory cells seem to develop normally in lymphoid tissues.
Experiments in which IL-4 was neutralized in vivo after
immunization clearly demonstrated that the effect of this cy-
tokine is exerted early during the first week after immuniza-
tion, at the time when the activated cells migrate to nonlym-
phoid organs. These findings indicate that IL-4/IL-4R
interactions that occur early after T cell activation are critical
to establish long living memory CD8  T cell populations in
nonlymphoid organs at a critical point when homeostatic
mechanisms are inducing a massive apoptosis on activated
cells that results in a severe contraction of the CD8  T cell re-
Figure 8. Homing properties and antiparasitic activity of adoptively 
transferred memory CD8  T cells. SIVPSAEQI-specific memory CD8  
T cells were generated from mice that received equal numbers of IL-4R KO 
naive transgenic cells and were immunized with irradiated sporozoites. 
20 d after immunization, tetramer /CD8  T cells were obtained from spleen. 
Equal numbers of normal or IL-4R KO tetramer-specific memory CD8  
T cells were transferred to naive mice. (A) Following adoptive transfer, the 
number of SIVPSAEQI-specific memory CD8  T cells in the spleen and liver 
was measured by ELISPOT at the indicated times. To determine the protec-
tive capacity of adoptive transferred memory cells, the naive recipient mice 
were challenged with 3   104 viable sporozoites 10 d after transfer of 
memory cells. 34 h later, the livers of infected mice were excised to 
measure the parasite load using real-time PCR (20). (B) The histograms 
represent the number of plasmodial rRNA copies. These data are represen-
tative of two independent experiments, using four mice per group.
Figure 9. Antiparasitic activity of CD62Llo and CD62Lhi memory 
CD8  T cells. SIVPSAEQI-specific memory CD8  T cells were generated 
from mice that received naive normal transgenic cells and were immunized 
with irradiated sporozoites. (A) 20 d after immunization, tetramer /CD8  
T cells obtained from spleen were costained with anti-CD62L. Line graph 
shows CD62L expression of tetramer /CD8  T cells. (B) To assess the anti-
parasitic activity of CD62Llow and CD62Lhigh memory CD8  T cells, these 
subpopulations were purified by cell sorting using flow cytometry. Equal 
numbers (1.5   106) of CD62Llo or CD62Lhi tetramer-specific CD8  T cells 
were transferred to naive mice. 2 d later, recipient mice were challenged 
with 3   104 viable sporozoites. 34 h after parasite challenge, the livers of 
infected mice were excised to measure the parasite load using real-time 
PCR (20). The histograms represent the number of plasmodial rRNA copies. 
The data are representative of two independent experiments, using four 
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sponse. Once CD8  T cells enter a resting phase and begin to
differentiate into memory cells, IL-4 seems to be dispensable.
Together, these results demonstrate, for the first time, that IL-4
can modulate the differentiation of memory CD8  T cells di-
rectly through the IL-4R that is expressed on these cells.
The results of the protection studies indicating that IL-
4R KO CD8  T cells lose their antiparasitic activity after
failing to maintain memory cells in nonlymphoid organs
suggest that this memory population—characterized by
their capacity to reside in nonlymphoid tissue—represents
the first line of defense against parasite infection in immune
hosts. Adoptive transfer experiments using purified mem-
ory spleen cells revealed additional features of this memory
population. Transfer of memory IL-4R KO cells obtained
from spleen 25 d after immunization, a time point at which
they are IL-4 independent and express CD62Lhi, indicated
that these cells can home to the liver and become capable
of inhibiting parasite development as efficiently as normal
memory cells. The results on the homing behavior of these
cells are not unexpected because it is known that memory
CD8  T cells, regardless of their tissue origin or CD62 ex-
pression, home with similar efficiency to lymphoid and
nonlymphoid organs after adoptive transfer (22, 23). It is
unclear whether this migration behavior represents a physi-
ologic trafficking pattern accelerated by the adoptive trans-
fer, or if this is an abnormal effect that is induced by the ex
vivo purification procedures and intravenous injection.
Nevertheless, the fact that memory IL-4R KO cells can
protect after adoptive transfer indicates that they are fully
capable of inhibiting parasite development if they reside in
the proper tissue compartments.
These findings appear to differ, at least in part, from
those obtained in studies using vaccinia and lymphocytic
choriomeningitis virus. In these viral systems, adoptively
transferred “central memory” CD8  T cells—defined by
the expression of CD62Lhi—represent the main protective
cell subset (7, 24). In the malaria system, we found that
adoptively transferred normal CD62Llo and CD62Lhi mem-
ory cells display a comparable antiparasitic activity. Most
importantly, the lack of protective activity by lymphoid
resident CD62Lhi IL-4R KO memory cells of unmanipu-
lated mice suggests that this subset may not have a protec-
tive role that is as prominent as that observed in viral infec-
tions. This apparent discrepancy between the viral and
parasite systems most likely reflects the biologic differences
that exist between these microbial infections. Particularly
important is the fact that the parasite stage that is suscepti-
ble to CD8  T cells develops only in the liver and last for
only 40–42 h, whereas viral infections affect several organs,
including lymphoid tissues, and remain detectable for sev-
eral days. In this situation, during viral infections, memory
CD8  T cells that reside in lymphoid organs may have
more opportunities to be reactivated and become full effec-
tor cells, and mask the early protective activity of memory
cells from nonlymphoid organs.
The selective effect of IL-4 in the development of mem-
ory CD8  T cells in nonlymphoid organs is intriguing be-
cause it seems to differ from that of IL-7 and IL-15, both of
which seem to affect the entire memory population at differ-
ent time points (i.e., IL-7 helps to maintains memory popu-
lations after they have developed, whereas IL-15 seems to be
important during T cell activation and after memory popula-
tions have been developed; references 8, 11). The molecular
mechanism that underlies the effect of these cytokines of the
 -chain receptor family on CD8  T cells remains poorly un-
derstood. Although the importance of IL-15/IL-15R inter-
actions at different stages of the CD8  T cell responses is
well documented, little is known about the molecular basis
of this cytokine effect. As for IL-7, recent studies indicate
that this cytokine promotes the survival of memory CD8  T
cells by increasing the expression of antiapoptotic molecules,
such as Bcl-XL and Bcl-2.
The mechanism by which the IL-4R modulates the de-
velopment of memory CD8  T cells in nonlymphoid organs
remains to be elucidated. It is conceivable that the decrease
of IL-4R KO memory cells in nonlymphoid organs may re-
sult from a reduced supply of memory cells from spleen, a
selective migration of activated cells to lymphoid organs, or a
decreased survival of memory cells in nonlymphoid organs.
Our results show that the magnitude of normal and IL-4R
KO CD8  T cell responses at day 4 are identical in every or-
gan. Moreover, at this time point the number of activated
cells in each organ reaches their highest levels; this indicates
that there is no lack of T cell migration from spleen or
lymph nodes toward nonlymphoid tissues. After day 4 there
is a pronounced reduction in the number of IL-4R KO
CD8  T cells in nonlymphoid organs. This may be ex-
plained by an accelerated emigration of activated cells to-
ward lymphoid tissues facilitated by a high expression of
CD62L, or it could be due to an increased death rate of acti-
vated cells in nonlymphoid organs. The idea that IL-4 en-
hances the survival of activated CD8  T cells is supported by
previous studies which described an antiapoptotic effect of
IL-4 on CD4  T cells (25), and by our current findings that
activated IL-4R KO CD8  T cells express lower levels of
the antiapoptotic molecule, Bcl-XL when compared with
activated normal cells. Further research is necessary to fully
resolve this issue.
The existence of various cytokine-mediated mechanisms
that affect the development of memory CD8  T cell re-
sponses raises questions regarding the possible interactions
that these cytokines may establish between themselves dur-
ing this process. Perhaps these cytokines act in concert—
with a certain degree of specialization—to perform distinct
tasks at different developmental phases of the T cell response.
Alternatively, it is conceivable that these cytokine/cytokine
receptor interactions might represent redundant functions
that ensure a proper development and establishment of
memory cells. Perhaps more important, it has yet to deter-
mined whether the same set of cytokines participates in theJEM VOL. 202, August 15, 2005 559
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development of all antimicrobial CD8  T cell responses. A
“one size fits all” model of CD8  T cell development may
be too simplistic; the degree of participation of each cyto-
kine may vary depending on the virulence of the infectious
pathogen, the tissue compartments that are affected, or the
pathology caused by the infection. A better characterization
of the mechanisms by which these cytokines sustain and reg-
ulate the development of memory CD8  T cells should
open new avenues for research that are aimed at manipulat-
ing this differentiation process with a view to enhance the
efficacy of T cell responses induced by vaccination.
MATERIALS AND METHODS
Mice and parasites. BALB/c mice were purchased from Taconic. The
generation of the P. yoelli–specific transgenic mice expressing a TCR spe-
cific for the SYVPSAEQI epitope using C57BL/6 oocytes was described
elsewhere (2). Original founders were crossed to BALB/c mice, and the
F20 backcross generation was used for the experiments. TCR transgenic/
IL-4R KO mice were obtained after crossing BALB/c IL-4R KO mice
(16) (provided by N. Noben-Trauth, George Washington Unversity Medi-
cal Center, Washington DC) with the P. yoelli–specific TCR transgenic
mice. Experiments with mice were approved by the Institutional Animal
Care and Use Committee of Johns Hopkins University.
Antibodies, flow cytometry, and ELISPOT.  All antibodies were pur-
chased from BD Biosciences, except antibody to mouse Bcl-XL and Bax
(Santa Cruz Biotechnology, Inc). Staining for Granzyme B was performed
using FITC-labeled anti–granzyme B obtained from Caltag (19). To stain
for CCR7, cells were incubated with CCL19 ligand–IgG at 1  g/ml (pro-
vided by J.G. Cyster, University of California, San Francisco, CA), followed
by goat anti–human Fc biotin and streptavidin-FITC. SYVPSAEQI-specific
H2Kd tetramer was prepared as described (2). FACS analysis of cells was
done using a FACSCalibur flow cytometer (200,000–500,000 gated events
per sample). CELLQuest software (Becton Dickinson) was used to analyze
the data. The ELISPOT assay to detect IFN-  and IL-2–secreting cells was
performed as described in detail (14, 26). Statistical analysis were done by
using analysis of variance, and a significance level of P   0.05 was used.
Adoptive transfer of transgenic cells, immunizations, and evalua-
tion of protective immunity. Spleen cells from transgenic mice con-
taining 106 tetramer /CD8  cells were used for adoptive transfers, unless
otherwise specified. Before transfer, the total number of transgenic cells
present in spleen was determined by FACS analysis after staining cells with
anti-CD8 and SYVPSAEQI-tetramers. Immunization with P. yoelii (17X
NL strain) sporozoites was done by i.v. injection of  -irradiated parasites.
To deplete endogenous CD8  T cell populations, BALB/c mice received
daily injections of 0.1 mg anti-CD8 antibody YTS 169 for 3 d, 4 d before
transfer of TCR transgenic CD8  T cells. Endogenous CD4  T cells were
depleted by treating mice with anti-CD4 antibodies (GK1.5) administered
by daily injections of 0.15 mg for 3 d before parasite challenge. The evalua-
tion of parasite development in liver of mice challenged with parasites was
performed by real time PCR, as described (20).
In vivo neutralization of IL-4. At the indicated days, mice received daily
i.p. injections of 0.1 mg of purified rat mAb 11B11 specific for mouse IL-4,
obtained from NCI Biological Resources Branch. Control mice received no
treatment or similar amounts of purified rat IgG (Pierce Chemical Co.).
Isolation of memory T cell subsets from spleen.  Memory CD8  T
cells were obtained from spleen of mice that received normal TCR trans-
genic CD8  T cells and were immunized with parasites, as described (2,
14). 20 d after immunization, spleen cells were enriched for CD8  T cells
by negative selection of CD4  T cells and B cells through magnetic sorting
using anti-CD4–FITC (L3T4), B220-FITC, and anti-FITC beads, follow-
ing the manufacturer’s instructions (Miltenyi Biotec). The total number of
tetramer /CD8  T cells was determined by FACS analysis. The purifica-
tion of the memory CD8  T cell subsets, CD62Lhi or CD62Llo, was ob-
tained by FACS cell sorting using tetramer-PE, anti CD8-APC, and anti-
CD62L–FITC.
Isolation of lymphocytes from nonlymphoid tissues. Before tissue
removal, mice were perfused with phosphate-buffered saline and heparin
(75 U/ml). Tissues were disrupted mechanically, suspended in HBSS with
2% FCS and 10 mM Hepes, and filtered through a 70- m mesh. This cell
suspension was centrifuged, the pellet was resuspended in a solution of Per-
coll (Amersham Biosciences) as described (10), centrifuged at 600 g, and
washed extensively before use.
CFSE labeling and proliferation of memory cells. BALB/c mice re-
ceiving 106 transgenic CD8  T cells were immunized with 50,000  -irradi-
ated sporozoites; 25 d later, lymphocytes were isolated from their lymph
nodes. After labeling in vitro with CFSE (Molecular Probes), the cells were
transferred i.v. into naive BALB/c mice that were immunized with 50,000
sporozoites. 3 d after immunization, the dilution profile of the CSFE label
in spleen cells from recipient mice was evaluated by FACS, gating in
tetramer /CD8  lymphocytes.
Online supplemental material. Fig. S1 shows the kinetics of the CD8 
T cell responses and the total numbers of tetramer /CD8  T cells in the
spleen. Fig. S2 shows the expression of Bcl-XL in activated tetramer /
CD8  T cells. Fig. S3 shows the phenotypes of activated and naive CD8  T
cells obtained from spleen. Fig. S4 presents the activation profile of normal
and IL-4R KO memory CD8  T cells obtained from spleen. Fig. S5 shows
the kinetics of the CD8  T cell responses in the lymph nodes. Fig. S6 pre-
sents the quantification of the CD8  T cell responses in the lungs and kid-
neys. Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20042463/DC1.
Flow cytometry was performed in the Becton Dickinson Immune Function 
Laboratory at the Johns Hopkins Bloomberg School of Public Health.
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